Wedbush Reiterates Outperform on Generation Bio, Maintains $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst David Nierengarten has reiterated an Outperform rating on Generation Bio (NASDAQ:GBIO) and maintained a $5 price target.
August 08, 2024 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst David Nierengarten has reiterated an Outperform rating on Generation Bio and maintained a $5 price target.
The reiteration of an Outperform rating and the maintenance of a $5 price target by a reputable analyst can boost investor confidence in Generation Bio, potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100